vs

Side-by-side financial comparison of Ispire Technology Inc. (ISPR) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $20.3M, roughly 1.1× Ispire Technology Inc.). Ispire Technology Inc. runs the higher net margin — -32.5% vs -36.8%, a 4.3% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -51.5%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs -17.8%).

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

ISPR vs PED — Head-to-Head

Bigger by revenue
PED
PED
1.1× larger
PED
$23.1M
$20.3M
ISPR
Growing faster (revenue YoY)
PED
PED
+169.7% gap
PED
118.2%
-51.5%
ISPR
Higher net margin
ISPR
ISPR
4.3% more per $
ISPR
-32.5%
-36.8%
PED
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
-17.8%
ISPR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ISPR
ISPR
PED
PED
Revenue
$20.3M
$23.1M
Net Profit
$-6.6M
$-8.5M
Gross Margin
17.1%
Operating Margin
-33.9%
-21.3%
Net Margin
-32.5%
-36.8%
Revenue YoY
-51.5%
118.2%
Net Profit YoY
17.4%
-243.5%
EPS (diluted)
$-0.12
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPR
ISPR
PED
PED
Q4 25
$20.3M
$23.1M
Q3 25
$30.4M
$7.0M
Q2 25
$20.1M
$7.0M
Q1 25
$26.2M
$8.7M
Q4 24
$41.8M
$10.6M
Q3 24
$39.3M
$9.1M
Q2 24
$37.3M
$11.8M
Q1 24
$30.0M
$8.1M
Net Profit
ISPR
ISPR
PED
PED
Q4 25
$-6.6M
$-8.5M
Q3 25
$-3.3M
$-325.0K
Q2 25
$-14.8M
$-1.7M
Q1 25
$-10.9M
$140.0K
Q4 24
$-8.0M
$5.9M
Q3 24
$-5.6M
$2.9M
Q2 24
$-3.5M
$2.7M
Q1 24
$-5.9M
$773.0K
Gross Margin
ISPR
ISPR
PED
PED
Q4 25
17.1%
Q3 25
17.0%
Q2 25
12.3%
Q1 25
18.2%
Q4 24
18.5%
Q3 24
19.5%
Q2 24
28.3%
Q1 24
20.4%
Operating Margin
ISPR
ISPR
PED
PED
Q4 25
-33.9%
-21.3%
Q3 25
-8.9%
-12.0%
Q2 25
-72.7%
-32.2%
Q1 25
-40.4%
1.7%
Q4 24
-17.6%
-12.9%
Q3 24
-13.4%
31.3%
Q2 24
-9.2%
22.3%
Q1 24
-18.8%
7.6%
Net Margin
ISPR
ISPR
PED
PED
Q4 25
-32.5%
-36.8%
Q3 25
-10.7%
-4.7%
Q2 25
-73.4%
-24.0%
Q1 25
-41.5%
1.6%
Q4 24
-19.1%
56.0%
Q3 24
-14.2%
32.2%
Q2 24
-9.4%
22.7%
Q1 24
-19.7%
9.5%
EPS (diluted)
ISPR
ISPR
PED
PED
Q4 25
$-0.12
$-2.23
Q3 25
$-0.06
$0.00
Q2 25
$-0.26
$-0.02
Q1 25
$-0.19
$0.00
Q4 24
$-0.14
$2.69
Q3 24
$-0.10
$0.03
Q2 24
$-0.07
$0.03
Q1 24
$-0.11
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPR
ISPR
PED
PED
Cash + ST InvestmentsLiquidity on hand
$17.6M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-7.7M
$207.4M
Total Assets
$84.4M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPR
ISPR
PED
PED
Q4 25
$17.6M
$3.2M
Q3 25
$22.7M
$10.9M
Q2 25
$24.4M
$8.5M
Q1 25
$23.5M
$10.4M
Q4 24
$34.4M
$4.0M
Q3 24
$37.7M
$4.6M
Q2 24
$35.1M
$6.1M
Q1 24
$39.5M
$13.3M
Stockholders' Equity
ISPR
ISPR
PED
PED
Q4 25
$-7.7M
$207.4M
Q3 25
$-1.8M
$115.4M
Q2 25
$604.7K
$115.2M
Q1 25
$14.8M
$116.2M
Q4 24
$24.2M
$115.6M
Q3 24
$30.7M
$106.5M
Q2 24
$34.5M
$103.2M
Q1 24
$35.9M
$100.0M
Total Assets
ISPR
ISPR
PED
PED
Q4 25
$84.4M
$375.9M
Q3 25
$96.4M
$135.9M
Q2 25
$102.2M
$136.8M
Q1 25
$115.7M
$145.6M
Q4 24
$132.0M
$128.3M
Q3 24
$129.0M
$114.3M
Q2 24
$122.6M
$111.0M
Q1 24
$108.0M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPR
ISPR
PED
PED
Operating Cash FlowLast quarter
$-4.0M
$-2.1M
Free Cash FlowOCF − Capex
$-4.0M
FCF MarginFCF / Revenue
-19.9%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPR
ISPR
PED
PED
Q4 25
$-4.0M
$-2.1M
Q3 25
$-1.2M
$7.4M
Q2 25
$4.7M
$-420.0K
Q1 25
$-12.5M
$5.9M
Q4 24
$-3.2M
$4.2M
Q3 24
$3.6M
$8.3M
Q2 24
$-1.4M
$4.6M
Q1 24
$3.4M
$-4.3M
Free Cash Flow
ISPR
ISPR
PED
PED
Q4 25
$-4.0M
Q3 25
$-1.2M
Q2 25
$3.7M
Q1 25
$-12.7M
Q4 24
$-3.2M
Q3 24
$3.3M
Q2 24
$-2.2M
Q1 24
$3.3M
FCF Margin
ISPR
ISPR
PED
PED
Q4 25
-19.9%
Q3 25
-3.9%
Q2 25
18.6%
Q1 25
-48.4%
Q4 24
-7.7%
Q3 24
8.5%
Q2 24
-5.9%
Q1 24
10.9%
Capex Intensity
ISPR
ISPR
PED
PED
Q4 25
0.3%
Q3 25
0.0%
Q2 25
4.8%
Q1 25
0.7%
Q4 24
0.1%
Q3 24
0.7%
Q2 24
2.0%
Q1 24
0.3%
Cash Conversion
ISPR
ISPR
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons